glp 1 course GLP-1-Based Therapies: Mechanisms of Action, Development, and Clinical Impact Medical Weight Loss GLP-1/GIP |

Seek medical advice within 24-48 hours if you experience: Dark urine that does not lighten after increasing your fluid intake (aim for pale yellow urine, but follow any specific fluid restriction advice if you have heart or kidney disease) Urine that appears tea-coloured, cola-coloured, or brown (suggesting possible bilirubin) Persistent dark urine lasting more than 2-3 days Accompanying symptoms such as pale stools or yellowing of the skin or eyes (jaundice) Reduced urine output or difficulty passing urine Unexplained fatigue, weakness, or confusion Seek immediate medical attention (contact 999 or attend A&E) if dark urine occurs alongside: Severe, persistent abdominal pain, particularly if accompanied by vomiting (possible pancreatitisstop taking Ozempic pending medical review) Persistent vomiting preventing fluid intake Signs of severe dehydration (dizziness when standing, rapid heartbeat, very dry mouth, sunken eyes) Fever with dark urine Heavy bleeding in urine with clots or inability to pass urine NICE guidance on acute kidney injury (NG148) emphasises the importance of monitoring patients on medications that may affect renal function, particularly when combined with dehydration

And unfortunately, this combination is not uncommon on GLP-1 medications, particularly during the first few weeks of treatment or after dose increases

One in eight people in the world are living with the condition, which has more than doubled in adults since 1990 and quadrupled in adolescents, according to World Health Organization

They produce weight loss (versus weight gain with insulin), have lower hypoglycemia risk, and have proven cardiovascular benefits that insulin lacks

Critically they need to be taken alongside physical exercise to be truly effective

Dosing starts low at 2.5mg weekly and increases every 4 weeks based on your response and tolerability